Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GBSciences

GBSciences
2001 FOUNDED
PUBLIC STATUS
51-60 EMPLOYEES
GBLX STOCK SYMBOL
2 INVESTMENTS
$0.06 SHARE PRICE (As of Friday Closing)
Description

GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

Formerly Known As
Diabetic Treatment Centers of America, Signature Exploration & Production, Flagstick Ventures, GrowBLOX Sciences
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 3550 West Teco Avenue
  • Las Vegas, NV 89118
  • United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GBSciences’s full profile, request a free trial.

GBSciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.04 - $0.28 $15.8M $0.06 -$0.12 497K 253M

GBSciences Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 46,247 60,556 79,976 43,832
Revenue 3,050 3,455 2,510 0
EBITDA (16,625) (18,340) (17,178) (8,766)
Net Income (20,892) (23,653) (22,974) (9,910)
Total Assets 30,468 30,023 24,050 13,007
Total Debt 11,221 8,685 7,554 3,929
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GBSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore GBSciences‘s full profile, request access.

Request full access to PitchBook

GBSciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (00 02-Aug-2017 00000 0000000 Other Pharmaceuticals and Biotechnology 0000 0000
LaurelCo 25-Jul-2014 Corporate Biotechnology 00000 000000
To view this company’s complete investment and acquisition history, request access »

GBSciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore GBSciences‘s full profile, request access.

Request full access to PitchBook

GBSciences Executive Team (12)

Name Title Board
Seat
Contact
Info
Steven Weldon Chief Executive Officer & Chief Financial Officer
John Poss Chief Executive Officer & Chairman
Ksenia Griswold Chief Financial Officer
Kevin Kuethe Chief Operating Officer
Andrea Small-Howard Ph.D Chief Science Officer & Board Member

4 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

GBSciences Board Members (4)

Name Representing Role Since Contact
Info
000000 00000-000000 00.0 GBSciences Chief Science Officer & Board Member 000 0000
0000 0000 GBSciences Chief Executive Officer & Chairman 000 0000

2 Former Board Members

You’re viewing 2 of 4 board members. Get the full list »